|
Vanguard FTSE Europe Index Fund ETF Shares | VGK | iShares MSCI Spain ETF | EWP | iShares MSCI Italy ETF | EWI | SPDR® EURO STOXX 50 ETF | FEZ | iShares MSCI EAFE Growth ETF | EFG | iShares MSCI France ETF | EWQ | iShares MSCI Japan ETF | EWJ | Vanguard FTSE Developed Markets Index Fund ETF Shares | VEA | SPDR® Dow Jones International Real Estate ETF | RWX | iShares MSCI Australia ETF | EWA |
Gross Expense Ratio*
0.08%
SEC 30 Day Yield (as of 12/31/22 )
--
Ann. Dividend/Yield
$2.48/4.09%
Ex-Dividend Date
12/19/2022
52-Wk Range
44.99 - 67.38
Fund Inception
03/04/2005
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe.The fund employs an indexing investment approach by investing all, or substantially all, of its assets in the common stocks included in the FTSE Developed Europe All Cap Index. The index is a market-capitalization-weighted index.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-1.67% |
-1.60% |
-1.67% |
-1.60% |
3-Month |
+21.00% |
+21.11% |
+21.00% |
+21.11% |
6-Month |
+6.17% |
+6.59% |
+6.17% |
+6.59% |
Year-to-date |
-16.01% |
-16.04% |
-16.01% |
-16.04% |
1-Year |
-16.01% |
-16.04% |
-16.01% |
-16.04% |
3-Year |
+1.16% |
+1.33% |
+1.16% |
+1.33% |
5-Year |
+1.92% |
+1.96% |
+1.92% |
+1.96% |
10-Year |
+4.66% |
+4.77% |
+4.66% |
+4.77% |
Since Inception |
+4.21% |
+4.22% |
+4.21% |
+4.22% |
Inception Date: March 04, 2005
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-16.01% |
-16.04% |
-16.01% |
-16.04% |
5-Year |
+1.92% |
+1.96% |
+1.92% |
+1.96% |
10-Year |
+4.66% |
+4.77% |
+4.66% |
+4.77% |
Since Inception |
+4.21% |
+4.22% |
+4.21% |
+4.22% |
Inception Date: March 04, 2005
Cyclical |
36.19% |
7.05% |
9.99% |
17.14% |
2.01% |
Defensive |
30.77% |
11.62% |
15.26% |
3.89% |
Sensitive |
33.02% |
4.40% |
6.32% |
15.09% |
7.21% |
Portfolio Details
|
Company |
YTD Return (as of 01/27/2023) |
% of Assets |
* Nestle SA |
+1.14% |
3.01% |
* Roche Holding AG |
+1.32% |
2.15% |
* ASML Holding NV |
+22.70% |
2.13% |
* Novo Nordisk A/S Class B |
+2.41% |
2.06% |
* Shell PLC |
+5.42% |
1.94% |
* AstraZeneca PLC |
-4.70% |
1.94% |
* Novartis AG |
-2.01% |
1.77% |
* LVMH Moet Hennessy Louis Vuitton SE |
+19.52% |
1.75% |
* TotalEnergies SE |
-1.74% |
1.41% |
* Unilever PLC |
-2.47% |
1.24% |
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|